Company Profiles

driven by the PitchBook Platform

3-V Biosciences

Description

Developer of therapeutics for the treatment of infectious diseases. The company focuses on discovering and developing novel therapeutics that modulate key pathways for the treatment of oncology and infectious disease.

2007

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$5.44M

Latest Deal Amount

$114M

Total Amount Raised

Description

Developer of therapeutics for the treatment of infectious diseases. The company focuses on discovering and developing novel therapeutics that modulate key pathways for the treatment of oncology and infectious disease.

Website:

www.3vbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

1050 Hamilton Court Menlo Park, CA 94025United States +1 (650) 561-8600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore 3-V Biosciences's full profile, request a free trial.

3-V Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

3-V Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

3-V Biosciences Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ally Bridge GroupVenture CapitalMinority000 0000000 0000
Kleiner Perkins Caufield & ByersVenture CapitalMinority000 0000000 0000
New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
Rock Springs CapitalHedge FundMinority000 0000000 0000
The Column GroupVenture CapitalMinority000 0000000 0000
Ally Bridge Group Venture Capital
Kleiner Perkins Caufield & Byers Venture Capital
New Enterprise Associates Venture Capital
Rock Springs Capital Hedge Fund
The Column Group Venture Capital

3-V Biosciences Executive Team (11)

NameTitleBoard
Seat
Contact
Info
George Kemble Ph.DChief Scientific Officer, Board Member & Chief Executive Officer
Chris HolmanDirector, Facilities
Gregory DukeDirector, Virology
Lucas Pelkmans Ph.DCo-Founder
Urs GreberCo-Founder
George Kemble Ph.D Chief Scientific Officer, Board Member & Chief Executive Officer
Chris Holman Director, Facilities
Gregory Duke Director, Virology
Lucas Pelkmans Ph.D Co-Founder
Urs Greber Co-Founder

3-V Biosciences Board Members (7)

NameRepresentingRoleSinceContact
Info
Beth Seidenberg MDKleiner Perkins Caufield & ByersBoard Member000 0000
David MottNew Enterprise AssociatesChairman000 0000
James Young Ph.DSelfBoard Member000 0000
Jason Fuller Ph.DNew Enterprise AssociatesBoard Member000 0000
Merdad Parsey Ph.D3-V BiosciencesBoard Member000 0000
Beth Seidenberg MD Board Member Kleiner Perkins Caufield & Byers
David Mott Chairman New Enterprise Associates
James Young Ph.D Board Member Self
Jason Fuller Ph.D Board Member New Enterprise Associates
Merdad Parsey Ph.D Board Member 3-V Biosciences
Request full access to PitchBook